Dendreon Files for FDA Approval of Provenge

Dendreon has completed its FDA submission for prostate cancer drug Provenge, reports CNBC's Mike Huckman. (CNBC)

MSNBC | November 2, 2009

Tags:. .huckman. .cnbc. .prostate. .fda. .submission